Odonate Therapeutics Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Odonate Therapeutics's estimated annual revenue is currently $9.3M per year.
- Odonate Therapeutics's estimated revenue per employee is $68,889
- Odonate Therapeutics has 135 Employees.
- Odonate Therapeutics grew their employee count by -3% last year.
- Odonate Therapeutics currently has 3 job openings.
What Is Odonate Therapeutics?
Odonate Therapeutics is dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Our initial focus is on the development of tesetaxel, an investigational, orally administered taxane. We are conducting our multinational, multicenter, randomized, Phase 3 study in locally advanced or metastatic breast cancer (MBC), known as CONTESSA. Our goal is to develop an effective chemotherapy choice for patients that provides quality-of-life advantages over current alternatives.keywords:N/A